Increased levels of heparanase (HPA) in pancreatic cancer increase metastatic potential by facilitating shedding of SDC1 as well as activation of the PI3K/AKT pathway and the epithelial-to-mesenchymal transition (Yang et al., 2007; Chen et al., 2020). The gene discussed is SDC1; the disease is pancreatic neoplasm.